Transient surface antigenemia in newborn infants vaccinated with Engerix B: occurrence and duration.
Neonatal Unit, Carmel Medical Center, B. Rappaport Faculty of Medicine, Haifa, Israel.
Z
Z
Weintraub
N
N
Khamaysi
H
H
Elena
V
V
Gershtein
L
L
Orenstein
N
N
Lahat
D000954:Antigens, Surface / Q000096:biosynthesis; D006509:Hepatitis B / Q000517:prevention & control*; D006511:Hepatitis B Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D007557:Israel; D011446:Prospective Studies; D013997:Time Factors; D014614:Vaccines, Synthetic / Q000009:adverse effects* / Q000276:immunology
D000954:Antigens, Surface; C075654:Engerix-B; D006511:Hepatitis B Antigens; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic